---
title: Frameshift mutations in peripheral blood as a biomarker for surveillance of
  lynch syndrome
date: '2024-03-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38466935/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240312025011&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: We demonstrated that FSMs can be detected in cfDNA from
  MSI-H/MMRd cases and asymptomatic carriers. The 122-target FSM panel described here
  has promise as a tool for improved surveillance of MSI-H/MMRd carriers with the
  potential to reduce the frequency of invasive screening methods for this high-cancer-risk
  ...'
disable_comments: true
---
CONCLUSIONS: We demonstrated that FSMs can be detected in cfDNA from MSI-H/MMRd cases and asymptomatic carriers. The 122-target FSM panel described here has promise as a tool for improved surveillance of MSI-H/MMRd carriers with the potential to reduce the frequency of invasive screening methods for this high-cancer-risk ...